SecBot SecBot
SECBOTREPLAY Home › Report › RVMDW

RVMDW · Revolution Medicines raised approximately $1.65 billion through a…

Revolution Medicines, Inc. · 8-K filed Apr 16, 2026 at 17:06 ET

At the news

NEUTRALIMPACT 6/10

8-K filed Apr 16, 2026 at 17:06 ET

Revolution Medicines raised approximately $1.65 billion through a public offering of 12.15 million common shares at $142.00 per share, alongside a separate $500 million convertible note offering. The proceeds will fund R&D, commercialization of product candidates, and general corporate purposes.

  • Company issued 12,147,887 shares of common stock (10,563,381 base + 1,584,506 option) at $142.00 per share
  • Net proceeds from equity offering estimated at $1.65 billion after underwriting discounts and expenses
  • Concurrent $500 million offering of 0.50% convertible senior notes due 2033
  • Proceeds to be used for R&D, potential commercialization of product candidates, general corporate purposes, and potential acquisitions

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access